Identification of gene expression profiling associated with erlotinib-related skin toxicity in pancreatic adenocarcinoma patients
Author:
Funder
Spanish Ministry of Economy and Competitiveness
Instituto de Salud Carlos III
Publisher
Elsevier BV
Subject
Pharmacology,Toxicology
Reference39 articles.
1. Phase II open-label study of erlotinib in combination with gemcitabine in unresectable and/or metastatic adenocarcinoma of the pancreas: relationship between skin rash and survival (Pantar study);Aranda;Ann. Oncol.,2012
2. Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysis;Arbitrio;Cancer Chemother. Pharmacol.,2016
3. Rash severity is predictive of increased survival with erlotinib hydrochloride;Clark;Proc. Am. Soc. Clin. Oncol.,2003
4. Phase II trial of gefitinib 250mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck;Cohen;Clin. Cancer Res.,2005
5. Transcriptome meta-analysis of peripheral lymphomononuclear cells indicates that gestational diabetes is closer to type 1 diabetes than to type 2 diabetes mellitus;Collares;Mol. Biol. Rep.,2013
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effects of paternal methionine supplementation on sperm DNA methylation and embryo transcriptome in sheep;Environmental Epigenetics;2022-12-23
2. The role of SELENBP1 and its epigenetic regulation in carcinogenic progression;Frontiers in Genetics;2022-11-01
3. Impact of posttranslational modifications in pancreatic carcinogenesis and treatments;Cancer and Metastasis Reviews;2021-08-03
4. FAM46C inhibits cell proliferation and cell cycle progression and promotes apoptosis through PTEN/AKT signaling pathway and is associated with chemosensitivity in prostate cancer;Aging;2020-04-13
5. Down-regulation of miR-10b represses cell vitality in osteosarcoma and is inversely associated with prognosis via interacting with FAM46C;Tissue and Cell;2020-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3